SCHEMBL8501757

SCHEMBL8501757

C=CC(c1ccccc1)c1ccc(OC)c(OC)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
MAPT P10636 6/20 0.49
CRHBP P24387 1/20 0.49
CRHR2 Q13324 1/20 0.49
KDM4E B2RXH2 4/20 0.46
HPGD P15428 4/20 0.46
KMT2A Q03164 4/20 0.46
MEN1 O00255 3/20 0.46
ALDH1A1 P00352 3/20 0.46
USP2 O75604 2/20 0.46
TP53 P04637 2/20 0.46
CYP3A4 P08684 2/20 0.46
ALOX15 P16050 2/20 0.46
HSD17B10 Q99714 2/20 0.46
LMNA P02545 1/20 0.46
ALOX12 P18054 1/20 0.46
CYP1A1 P04798 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP1B1 Q16678 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28221547 0.85 NFE2L2 (0.50) TDP1L3MBTL1MAPTKMT2AMEN1
SCHEMBL4826210 0.84 PDE4A (0.63) PDE4A
SCHEMBL5877045 0.83 L3MBTL1 (0.53) TDP1L3MBTL1MAPTCRHBPCRHR2
SCHEMBL1515750 0.83 L3MBTL1 (0.53) TDP1L3MBTL1MAPTCRHBPCRHR2
SCHEMBL8499958 0.81 ALDH1A1 (0.47) L3MBTL1MAPTKDM4EKMT2AMEN1
SCHEMBL24065953 0.79 MAPT (0.53) TDP1L3MBTL1MAPTKDM4EHPGD
SCHEMBL28606777 0.79 L3MBTL1 (0.58) TDP1L3MBTL1MAPTCRHBPCRHR2
SCHEMBL28639731 0.78 KDM4E (0.52) TDP1MAPTKDM4EHPGDKMT2A
SCHEMBL17616789 0.78 L3MBTL1 (0.50) TDP1L3MBTL1MAPTCRHBPCRHR2
SCHEMBL8784523 0.77 MAPT (0.69) TDP1L3MBTL1MAPTCRHBPCRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0918746-A1 IMMUNOTHERAPEUTIC AGENTS AND THEIR USE IN THE REDUCTION OF CYTOKINE LEVELS CELGENE CORPORATION (US) 1999-06-02 EP disclosed
WO-1998006692-A1 NOVEL IMMUNOTHERAPEUTIC AGENTS AND THEIR USE IN THE REDUCTION OF CYTOKINE LEVELS CELGENE CORPORATION (US) 1998-02-19 WO disclosed